Search

Your search keyword '"Allergan PLC -- Product development"' showing total 24 results

Search Constraints

Start Over You searched for: Descriptor "Allergan PLC -- Product development" Remove constraint Descriptor: "Allergan PLC -- Product development" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
24 results on '"Allergan PLC -- Product development"'

Search Results

1. PRESBYOPIA DRUGS: A DROP IN THE BUCKET?

2. New Therapeutics Expand Intervention Options: The innovations include a refutable implant that treats AMD with far fewer injections, an eye drop for presbyopia that constricts pupils and a nasal spray that boosts tear production

3. Ireland : Allergan Announces Positive Phase 3 Achieve I Trial Results For Ubrogepant Published In The New England Journal Of Medicine

4. Ireland : Allergan Announces Positive Phase 3 Achieve Ii Trial Results For Ubrogepant Published In The Journal Of The American Medical Association

5. Data on Gastroparesis Detailed by Researchers at Mayo Clinic (Overall Safety of Relamorelin In Adults With Diabetic Gastroparesis: Analysis of Phase 2a and 2b Trial Data)

6. Ireland : Allergan Announces Positive Topline Phase 3 Clinical Data for Bimatoprost SR (Sustained-Release) Implant for IOP Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension

7. Ireland : Allergan's Oral CGRP Receptor Antagonist Atogepant Demonstrates Robust Efficacy and Safety in Episodic Migraine Prevention in a Phase 2b|3 Clinical Trial

8. Byvalson

9. Ireland : Allergan Presented New Phase 3 Data of Ulipristal Acetate in Women with Uterine Fibroids at the American Society for Reproductive Medicine Annual Congress

10. United States : Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress

11. Ireland : FDA approves Allergan's sNDA for AVYCAZ (ceftazidime and avibactam) to include new Phase III data in Patients with Complicated Urinary Tract Infections (cUTI), Including Pyelonephritis

12. Medicines360 and Allergan Present 5-Year Trial Data from Largest On-going IUS Clinical Study

13. Sarecycline

14. Ireland : Amgen And Allergan Announce Top-Line Results From Phase 3 Study Evaluating ABP 980 Compared With Trastuzumab In Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer

15. United States : USFDA approves Allergan's NDA filing for Oxymetazoline HCI cream 1.0%

16. Dapsone gel 7.5%

17. Onabotulinumtoxin A injection

18. Cariprazine capsules

19. Ceftazidime-avibactam

20. Levonorgestrel-releasing intrauterine system

21. Clobetasol cream 0.05%

22. Ironwood Reports Positive Top-Line Data from Phase II Trial of Linaclotide in Adult Patients With Opioid-Induced Constipation

24. Richter and Actavis Announce Positive Phase III Results for Cariprazine in the Prevention of Relapse in Patients with Schizophrenia

Catalog

Books, media, physical & digital resources